[1]
Hussain A.M., Flint N.J., Livsey S.A.,et al.: Bickerstaff’s brainstem encephalitis related to Campylobacter jejuni gastroenteritis. J. Clin. Pathol. 2007; 60: 1161–1162.
[2]
Steer AC., Starr M., Kornberg AJ.: Bickerstaff Brainstem Encephalitis Associated With Mycoplasma pneumoniae Infection. J. Child Neurology 2006; 21(6): 533–534. Doi: 10.1177/08830738060210061401.
[3]
Ito M., Kuwabara S., Odaka M., et al.: Bickerstaff’s brainstem encephali-tis and Fisher syndrome form a continuous spectrum: Clinical analysis of 581 cases. Journal of Neurology 2008; 255(5): 674–682. Doi: 10.1007/s00415-008-0775-0.
[4]
Wu L., Wu WP., Huang DH., et al.: Clinical presentations and differential diagnosis of Miller-Fisher syndrome and Bickerstaff brainstem encepha-litis. J Clin Neurol 2007;2 0: 84–86.
[5]
Yuki N.: Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome).J Neuroimmunol 2009; 215:1–9.
[6]
Liu JX., Willison HJ., Pedrosa-Domellof F.: Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009; 50: 3226–3232.
[7]
Michev A., Musso P., Foiadelli T., et al.: Bickerstaff Brainstem Encepha-litis and overlapping Guillain-Barré syndrome in children: Report of two cases and review of the literature. Eur J Paediatr Neurol. 2019 Jan; 23(1): 43–52. Doi: 10.1016/j.ejpn.2018.11.008. Epub 2018 Nov 20. Re-view.
[8]
Uncini A., Manzoli C., Notturno F., et al.: Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010; 81: 1157–1163.
[9]
Lo YL.: Clinical and immunological spectrum of the Miller Fisher syn-drome. Muscle Nerve 2007; 36: 615–627.
[10]
Odaka M., Yuki N., Yamada M., et al.: Bickerstaff’s brainstem encephali-tis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003;126(Pt 10): 2279–2290. PMID: 12847079.
[11]
Zhang G., Li Q., Zhang R.,et al.: Subtypes and Prognosis of GuillainBarré Syndrome in Southwest China. PLoS One 2015; 10(7): e0133520. Doi: 10.1371/journal.pone.0133520.
[12]
Zhuo XW., Ding CH., Li JW.,et al.: Clinical features of 19 children with Bick-erstaff brainstem encephalitis]. Chinese journal of pediatrics. 2019 May 2; 57(5): 363–367. doi: 10.3760/cma.j.issn.0578-1310.2019.05.009.
[13]
Overell JR., Hsieh ST., Odaka M., et al.: Treatment for Fisher syndrome, Bickerstaff’s brainstem encephalitis and related disorders.Cochrane Da-tabase Syst Rev 2007; (1): CD004761.
[14]
Mori M., Kuwabara S., Fukutake T., et al.: Intravenous immunoglobulin therapy for Miller Fisher syndrome.Neurology 2007; 68:1144–1146.
[15]
Hughes RAC., Swan AV., Raphael JC., et al.: Immunotherapy for Guil-lain-Barré syndrome: a systematic review.Brain 2007;130:2245–2257.
[16]
Lünemann JD., Nimmerjahn F., Dalakas MC.: Intravenous immunoglobu-lin in neurologymode of action and clinical efficacy. Nat Rev Neurology 2015: 80–89. Doi: 10.1038/nrneurol.2014.253.
[17]
Rho Y Il.: Overlapping Guillain-Barré syndrome and Bickerstaff’s brain-stem encephalitis associated with Epstein Barr virus. Korean J Pediatr 2014; 57(10): 457–460. Doi: 10.3345/kjp.2014.57.10.457.
, Małgorzata Bocheńska
Scholar Google
PubMed